Evaluation of Endocrine and Metabolic Parameters in the New Diagnostic Phenotypes of Polycystic Ovary Syndrome
Adipokines as Predictors of the Metabolic Syndrome in ALL Survivors
Impact of Liraglutide 3.0 on Body Fat Distribution
Metformin and Lifestyle Intervention in Women With Polycystic Ovary Syndrome
† Study has passed its completion date and status has not been verified in more than two years.